VJHemOnc is committed to improving our service to you

MPN Advances Day 2019 | Single-cell multiomics to study malignant megakaryocytes

VJHemOnc is committed to improving our service to you

Bethan Psaila

Bethan Psaila, MBBS, MRCP, FRCPath, PhD, University of Oxford, Oxford, UK, discusses the future prospects of immunotherapy in myeloproliferative neoplams (MPNs), highlighting current research on novel targets that might selectively be expressed in the mutant clone of hematopoietic stem cells. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter